B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520) | Finanzwire

Basculer en Français

10603	Companies
224984	Keywords
153702	Articles
119046	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

BRIEF

published on 05/28/2026 at 07:35, 22 days 11 hours ago

BRAIN Biotech AG Releases H1 Financials and Maintains Full-Year Forecast

Revenue Decline Half-year Results BRAIN Biotech AG BioSolutions Genome Editing
PRESS RELEASE

published on 05/28/2026 at 07:30, 22 days 11 hours ago

BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26, with sequential growth in core segment BRAINBiocatalysts and a new European patent for genome editing. Full year guidance confirmed

Financial Forecast Half-year Results BRAIN Biotech AG EU Patent Genome Editing
BRIEF

published on 03/23/2026 at 11:10, 2 months 27 days ago

BRAIN Biotech Secures Patent for CRISPR-BMC Technology

BRAIN Biotech Genome-editing CRISPR-BMC Patent Granted Licensing Potential
PRESS RELEASE

published on 03/23/2026 at 11:05, 2 months 27 days ago

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
BRAIN Biotech secures key patent for CRISPR-BMC genome-editing technology, opening potential for commercial use through licensing. Nuclease exhibits high activity in various organisms

Patent BRAIN Biotech Licensing CRISPR-BMC Genome-editing Technology
BRIEF

published on 03/11/2026 at 17:10, 3 months 8 days ago

BRAIN Biotech AG 2026 AGM Results

Annual General Meeting Supervisory Board BRAINBiocatalysts Two-pillar Strategy Enzyme Production
PRESS RELEASE

published on 03/11/2026 at 17:05, 3 months 8 days ago

Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG
Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG. Shareholders approve all agenda items. New member elected to the Supervisory Board. CEO highlights company's strategy and unique selling points

Annual General Meeting Financial Year Supervisory Board BRAIN Biotech AG Product Innovations
BRIEF

published on 02/25/2026 at 07:35, 3 months 22 days ago

BRAIN Biotech Reports Q1 Results and SolasCure's Clinical Milestone

Financial Performance BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
PRESS RELEASE

published on 02/25/2026 at 07:30, 3 months 22 days ago

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
BRAIN Biotech's Q1 25/26 results show revenue decline but improved EBITDA. Breakthrough Aurase Wound Gel by SolasCure for chronic wounds. BRAIN BioIncubator segment thrives

EBITDA BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
BRIEF

published on 01/14/2026 at 07:35, 5 months 5 days ago

BRAIN Biotech AG Shows Resilience Amid Economic Challenges in FY 2024/25

Revenue Decline BRAIN Biotech AG Cost Control Financial Year 2024/25 BRAINBioIncubator
PRESS RELEASE

published on 01/14/2026 at 07:30, 5 months 5 days ago

FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control
BRAIN Biotech AG reports FY 2024/25 financial results showing successful project monetization and cost control measures. Decline in revenues offset by strong cash position

Financial Results Revenue Decline BRAIN Biotech AG Cost Control Project Monetization

1 2 ... 9

Accesswire

Published on 06/19/2026 at 04:30, 14 hours 12 minutes ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 17 hours 22 minutes ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 17 hours 35 minutes ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:55, 17 hours 47 minutes ago

INEO Announces Grant of Stock Options
Published on 06/19/2026 at 00:00, 18 hours 42 minutes ago

Redwood AI Announces Initiation of Chemical Risk Assessment Module

View all ACCESSWIRE

EQS Group

Published on 06/19/2026 at 18:29, 13 minutes ago

Designated Person Notification
Published on 06/19/2026 at 18:00, 42 minutes ago

Successful issue of a CHF 100 million green bond
Published on 06/19/2026 at 16:30, 2 hours 12 minutes ago

Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada
Published on 06/19/2026 at 16:05, 2 hours 36 minutes ago

ETOE Launches Dolphin 2 Portable RGB Triple-Laser Projector with Google TV
Published on 06/19/2026 at 15:48, 2 hours 54 minutes ago

Halfords Group PLC: Engage Retail Investor event - 25th June 12.00 BST

Les Echos

Published on 06/18/2026 at 18:00, 1 day ago

Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 1 day ago

EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 1 day 1 hour ago

Statement of transactions in own shares from June 8, 2026 to June 12, 2026
Published on 06/18/2026 at 13:00, 1 day 5 hours ago

Edenred statement
Published on 06/18/2026 at 09:06, 1 day 9 hours ago

Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany

View all LES ECHOS COMFI WIRE